EX-FILING FEES 7 dp208309_exfilingfees.htm EXHIBIT 107

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form F-3

(Form Type)

 

AC Immune SA

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type		   Security Class
Title		   Fee Calculation
or Carry Forward
Rule		   Amount
Registered 		  Proposed
Maximum
Offering
Price Per
Unit		   Maximum
Aggregate
Offering
Price		   Fee
Rate 		  Amount of
Registration
Fee		   Carry
Forward  Form
Type		   Carry Forward  File Number   Carry
Forward
Initial
Effective
Date		   Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
Newly Registered Securities
Fees to Be Paid   Equity   Common Shares   Rule 457(o)   (1)   (1)   (1)   (1)   (1)                
    Debt   Securities   Rule 457(o)   (1)   (1)   (1)   (1)   (1)                
    Other   Warrants   Rule 457(o)   (1)   (1)   (1)   (1)   (1)                
    Other   Purchase Contracts   Rule 457(o)   (1)   (1)   (1)   (1)   (1)                
    Other   Subscription Rights   Rule 457(o)   (1)   (1)   (1)   (1)   (1)                
    Other   Units   Rule 457(o)   (1)   (1)   (1)   (1)   (1)                
    Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   Rule 457(o)   (1)   (1)   $350,000,000   0.00014760   $51,660                
Fees Previously Paid   N/A   N/A   N/A   N/A   N/A   N/A       N/A                
Carry Forward Securities
Carry Forward Securities   N/A   N/A   N/A   N/A       N/A           N/A   N/A   N/A   N/A
    Total Offering Amounts       $350,000,000       $51,660                
    Total Fees Previously Paid       N/A       N/A                
    Total Fee Offsets       $35,892.29       N/A                
    Net Fee Due               $15,767.71                

 

(1)Omitted pursuant to General Instruction II.C to Form F-3. The amount to be registered consists of up to $350,000,000 of an indeterminate amount of common shares, debt securities, warrants, purchase contracts, subscription rights and/or units that may be offered and sold from time to time in one or more offerings.

 

 

 

Table 2: Fee Offset Claims and Sources

 

    Registrant or Filer Name   Form or Filing Type   File Number   Initial Filing Date   Filing Date   Fee Offset Claimed   Security Associated with Fee Offset Claimed   Security Title Associated with Fee Offset Claimed   Unsold Securities Associates with Fee Offset Claimed   Unsold Aggregate Offering Amount Associated with Fee Offset Claimed   Fee Paid with Fee Offset Source
Rule 457(p) and Rule 415(a)(6)
Fee Offset Claim   AC Immune SA   F-3   333-255576   April 28, 2021       $11,517.29   Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   $291,893,690 (1)    
Fee Offset Claim   AC Immune SA   F-3   333-224694   May 4, 2018       $24,375   Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   $223,411,644 (2)    
Fee Offset Source   AC Immune SA   F-3   333-255576       April 28, 2021                       $13,810 (1)
Fee Offset Source   AC Immune SA   F-3   333-224694       May 4, 2018                       $43,575 (2)

 

(1)AC Immune SA (the “Registrant”) previously filed a registration statement on Form F-3 (File No. 333-255576), initially filed on April 28, 2021 and declared effective on May 5, 2021 (the “2021 Prior Registration Statement”) and which registered the offer and sale of an indeterminate number of common shares, principal amount of debt securities, purchase contracts, warrants to purchase common shares, debt securities or other securities, units and subscription rights (collectively, the “Shelf Securities”) having an aggregate initial offering price not to exceed $350,000,000. The 2021 Prior Registration Statement was not fully used and $291,893,690 of the Shelf Securities remain unsold. As a result, the Registrant has $24,375 in unused filing fees associated with the 2021 Prior Registration Statement. In accordance with Rule 457(p) under the Securities Act, the registrant is using the unused filing fees to offset the filing fee payable in connection with this filing. Pursuant to Rule 415(a)(6) under the Securities Act, the filing fee of $24,375 relating to the Unsold Securities under the 2021 Prior Registration Statement, which was paid under the 2021 Prior Registration Statement, will continue to be applied to the Unsold Securities registered pursuant to this registration statement. To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the registrant sells any Unsold Securities pursuant to the 2021 Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated amount of Unsold Securities from the 2021 Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6). Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the 2021 Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. The filing fee of $24,375 relating to the Unsold Securities under the 2021 Prior Registration Statement, which was paid under the 2021 Prior Registration Statement, will continue to be applied to the Unsold Securities registered pursuant to this registration statement.

 

(2)AC Immune SA (the “Registrant”) previously filed a registration statement on Form F-3 (File No. 333-224694), initially filed on May 4, 2018 and declared effective on June 8, 2018 (the “2018 Prior Registration Statement”) and which registered the offer and sale of an indeterminate number of common shares, principal amount of debt securities, purchase contracts, warrants to purchase common shares, debt securities or other securities, units and subscription rights (collectively, the “Shelf Securities”) having an aggregate initial offering price not to exceed $350,000,000. The 2018 Prior Registration Statement was not fully used and $223,411,644 of the Shelf Securities remain unsold. As a result, the Registrant has $11,517.29 in unused filing fees associated with the 2018 Prior Registration Statement. In accordance with Rule 457(p) under the Securities Act, the registrant is using the unused filing fees to offset the filing fee payable in connection with this filing. Pursuant to Rule 415(a)(6) under the Securities Act, the filing fee of $11,517.29 relating to the Unsold Securities under the 2018 Prior Registration Statement, which was paid under the 2018 Prior Registration Statement, will continue to be applied to the Unsold Securities registered pursuant to this registration statement. To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the registrant sells any Unsold Securities pursuant to the 2018 Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated amount of Unsold Securities from the 2018 Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6). Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the 2018 Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. The filing fee of $11,517.29 relating to the Unsold Securities under the 2018 Prior Registration Statement, which was paid under the 2018 Prior Registration Statement, will continue to be applied to the Unsold Securities registered pursuant to this registration statement